Edition:
United Kingdom

Ankur Banerjee

GSK raises profit forecast after shingles vaccine sales boost

30 Oct 2019

GlaxoSmithKline on Wednesday raised its annual profit forecast for the second time this year as sales of its shingles vaccine beat expectations and older medicines, including HIV treatments, continued to sell well.

AstraZeneca raises sales forecast after surge in cancer drugs

24 Oct 2019

AstraZeneca lifted its annual drug sales forecast for the second time this year after a surge in revenue from newer cancer treatments, but warned that changing policies in China, its second-biggest market, would crimp growth next year.

For would-be elite soldiers, healthier diets may pay off

27 Sep 2019

(Reuters Health) - A study of soldiers trying to get into an elite army unit adds to evidence linking healthy diets to better physical performance.

Customers can make fast-food combo meals healthier

26 Aug 2019

(Reuters Health) - Combination meals in U.S. fast food and fast casual restaurants have lots of calories, saturated fat, sugar and sodium, but customers can make the meals healthier by substituting drinks and toppings, researchers say.

Pfizer to spinoff, merge off-patent drugs unit with Mylan

29 Jul 2019

Pfizer Inc has agreed to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV , a move that leaves Pfizer with its more profitable innovative drugs, including cancer treatment Ibrance and pneumonia vaccine Prevnar. | Video

AstraZeneca raises sales forecast after second quarter cancer drug, China boost

25 Jul 2019

AstraZeneca Plc raised its product sales forecast for 2019 on Thursday after second-quarter results beat analysts' expectations, thanks to strong sales from cancer medicines and emerging markets, especially China.

GSK raises 2019 earnings expectations after standout quarter for Shingrix

24 Jul 2019

GlaxoSmithKline beat second quarter profit expectations with the help of strong demand for its shingles vaccine, prompting the British drugmaker to forecast a smaller fall in profit this year than originally anticipated. | Video

AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan

25 Jun 2019

Drugmaker AbbVie Inc said on Tuesday it would acquire Allergan Plc for about $63 billion (£49.6 billion), giving AbbVie control over the lucrative wrinkle treatment Botox and buying time to seek new growth before its blockbuster arthritis treatment Humira loses U.S. patent protection. | Video

Migraine in pregnancy linked with complications for mothers and babies

25 Jun 2019

(Reuters Health) - Pregnant women with migraine headaches are more likely to develop complications, and their babies are at higher risk for complications early after birth, too, a large study from Denmark suggests.

World News